Annual revenue:
$57.88M+$21.60M(+59.55%)Summary
- As of today (June 22, 2025), NTLA annual revenue is $57.88 million, with the most recent change of +$21.60 million (+59.55%) on December 31, 2024.
- During the last 3 years, NTLA annual revenue has risen by +$24.82 million (+75.10%).
- NTLA annual revenue is now -0.20% below its all-time high of $57.99 million, reached on December 31, 2020.
Performance
NTLA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$16.63M+$3.75M(+29.15%)Summary
- As of today (June 22, 2025), NTLA quarterly revenue is $16.63 million, with the most recent change of +$3.75 million (+29.15%) on March 31, 2025.
- Over the past year, NTLA quarterly revenue has dropped by -$12.31 million (-42.54%).
- NTLA quarterly revenue is now -42.54% below its all-time high of $28.93 million, reached on March 31, 2024.
Performance
NTLA Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$45.57M-$12.31M(-21.27%)Summary
- As of today (June 22, 2025), NTLA TTM revenue is $45.57 million, with the most recent change of -$12.31 million (-21.27%) on March 31, 2025.
- Over the past year, NTLA TTM revenue has dropped by -$7.04 million (-13.37%).
- NTLA TTM revenue is now -26.90% below its all-time high of $62.34 million, reached on September 30, 2020.
Performance
NTLA TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NTLA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.5% | -42.5% | -13.4% |
| 3 y3 years | +75.1% | +47.8% | +20.4% |
| 5 y5 years | +34.3% | +28.7% | -0.0% |
NTLA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.1% | -42.5% | +967.3% | -21.3% | +25.6% |
| 5 y | 5-year | -0.2% | +75.1% | -42.5% | +967.3% | -26.9% | +70.1% |
| alltime | all time | -0.2% | +857.6% | -42.5% | +967.3% | -26.9% | +3443.5% |
NTLA Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $16.63M(+29.2%) | $45.57M(-21.3%) |
| Dec 2024 | $57.88M(+59.6%) | $12.87M(+41.3%) | $57.88M(+34.3%) |
| Sep 2024 | - | $9.11M(+31.0%) | $43.09M(-6.3%) |
| Jun 2024 | - | $6.96M(-76.0%) | $45.97M(-12.6%) |
| Mar 2024 | - | $28.93M(-1609.4%) | $52.60M(+45.0%) |
| Dec 2023 | $36.27M(-30.4%) | -$1.92M(-116.0%) | $36.27M(-29.9%) |
| Sep 2023 | - | $11.99M(-11.8%) | $51.77M(-2.4%) |
| Jun 2023 | - | $13.59M(+7.8%) | $53.04M(-0.8%) |
| Mar 2023 | - | $12.61M(-7.1%) | $53.48M(+2.6%) |
| Dec 2022 | $52.12M(+57.7%) | $13.57M(+2.3%) | $52.12M(+1.4%) |
| Sep 2022 | - | $13.27M(-5.4%) | $51.40M(+13.4%) |
| Jun 2022 | - | $14.03M(+24.7%) | $45.34M(+19.8%) |
| Mar 2022 | - | $11.25M(-12.5%) | $37.86M(+14.5%) |
| Dec 2021 | $33.05M(-43.0%) | $12.85M(+78.4%) | $33.05M(+23.4%) |
| Sep 2021 | - | $7.20M(+10.0%) | $26.79M(-35.9%) |
| Jun 2021 | - | $6.55M(+1.6%) | $41.81M(-18.9%) |
| Mar 2021 | - | $6.45M(-2.3%) | $51.52M(-11.2%) |
| Dec 2020 | $57.99M | $6.59M(-70.3%) | $57.99M(-7.0%) |
| Sep 2020 | - | $22.22M(+36.6%) | $62.34M(+22.9%) |
| Jun 2020 | - | $16.26M(+25.9%) | $50.73M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $12.92M(+18.1%) | $45.59M(+5.8%) |
| Dec 2019 | $43.10M(+41.6%) | $10.94M(+3.0%) | $43.10M(+7.6%) |
| Sep 2019 | - | $10.62M(-4.5%) | $40.05M(+8.7%) |
| Jun 2019 | - | $11.12M(+6.6%) | $36.84M(+10.3%) |
| Mar 2019 | - | $10.43M(+32.4%) | $33.40M(+9.7%) |
| Dec 2018 | $30.43M(+16.5%) | $7.88M(+6.4%) | $30.43M(+4.1%) |
| Sep 2018 | - | $7.41M(-3.5%) | $29.22M(+0.3%) |
| Jun 2018 | - | $7.68M(+2.8%) | $29.13M(+6.4%) |
| Mar 2018 | - | $7.47M(+12.0%) | $27.37M(+4.8%) |
| Dec 2017 | $26.12M(+58.5%) | $6.67M(-8.9%) | $26.12M(+4.2%) |
| Sep 2017 | - | $7.32M(+23.7%) | $25.08M(+10.8%) |
| Jun 2017 | - | $5.92M(-4.8%) | $22.63M(+8.2%) |
| Mar 2017 | - | $6.21M(+10.4%) | $20.92M(+26.9%) |
| Dec 2016 | $16.48M(+172.7%) | $5.63M(+15.6%) | $16.48M(+31.4%) |
| Sep 2016 | - | $4.87M(+15.8%) | $12.54M(+34.0%) |
| Jun 2016 | - | $4.21M(+136.7%) | $9.36M(+43.3%) |
| Mar 2016 | - | $1.78M(+5.0%) | $6.54M(+8.1%) |
| Dec 2015 | $6.04M | $1.69M(+0.3%) | $6.04M(+38.9%) |
| Sep 2015 | - | $1.69M(+22.6%) | $4.35M(+63.4%) |
| Jun 2015 | - | $1.38M(+7.1%) | $2.66M(+107.1%) |
| Mar 2015 | - | $1.29M | $1.29M |
FAQ
- What is Intellia Therapeutics annual revenue?
- What is the all time high annual revenue for Intellia Therapeutics?
- What is Intellia Therapeutics annual revenue year-on-year change?
- What is Intellia Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly revenue year-on-year change?
- What is Intellia Therapeutics TTM revenue?
- What is the all time high TTM revenue for Intellia Therapeutics?
- What is Intellia Therapeutics TTM revenue year-on-year change?
What is Intellia Therapeutics annual revenue?
The current annual revenue of NTLA is $57.88M
What is the all time high annual revenue for Intellia Therapeutics?
Intellia Therapeutics all-time high annual revenue is $57.99M
What is Intellia Therapeutics annual revenue year-on-year change?
Over the past year, NTLA annual revenue has changed by +$21.60M (+59.55%)
What is Intellia Therapeutics quarterly revenue?
The current quarterly revenue of NTLA is $16.63M
What is the all time high quarterly revenue for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly revenue is $28.93M
What is Intellia Therapeutics quarterly revenue year-on-year change?
Over the past year, NTLA quarterly revenue has changed by -$12.31M (-42.54%)
What is Intellia Therapeutics TTM revenue?
The current TTM revenue of NTLA is $45.57M
What is the all time high TTM revenue for Intellia Therapeutics?
Intellia Therapeutics all-time high TTM revenue is $62.34M
What is Intellia Therapeutics TTM revenue year-on-year change?
Over the past year, NTLA TTM revenue has changed by -$7.04M (-13.37%)